Company
Headquarters: Changyuan, China
Employees: 1,606
HK$1.59 Billion
HKD as of Jan. 1, 2024
US$203.6 Million
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Honliv Healthcare Management Group Company Limited operates private general hospitals in China. Its facilities include general healthcare services, such as obstetrics and gynecology, cardiovascular, orthopedics, nephrology and rheumatology, pediatrics, neurology, neonatal, gastroenterology, oncology, neurosurgery, endocrinology, gastrointestinal and hepatobiliary surgery, respiratory, emergency treatment, thyroid and breast surgery, ICU, thoracic surgery, otorhinolaryngology, cardiac surgery, hematology, infectious disease, urology, dermatology, rehabilitation, ophthalmology, pain treatment, proctology, stomatology, traditional Chinese medicine treatment, and plastic surgery services; anesthesiology, clinical laboratory and medical imaging services; and pharmaceuticals sales at hospital. The company also offers medical examination, disease screening, and other services to governmental and corporate customers in Changyuan County; and hospital management services. As of June 15, 2020, it owned one private general hospital and managed one private general hospital with 1,500 beds in operation located in Henan Province. The company was founded in 2004 and is headquartered in Changyuan, China. Honliv Healthcare Management Group Company Limited is a subsidiary of Sunny Rock Capital Limited.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Honliv Healthcare Management Group Company Ltd has the following listings and related stock indices.
Stock: HKEX: 9906 wb_incandescent